MirImmune's Acquisition

MirImmune was acquired by RXi Pharmaceuticals on October 13, 2016.

MirImmune is a biopharmaceutical company focusing on the development of immunotherapies for cancer by combining two approaches to cancer treatment: immune checkpoint inhibition and cell-based immunoth…

Articles about MirImmune's Acquisition: